Free Trial

Strong Tower Advisory Services Has $2.54 Million Stock Holdings in Corteva, Inc. (NYSE:CTVA)

Corteva logo with Consumer Staples background

Strong Tower Advisory Services raised its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 16.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 40,308 shares of the company's stock after purchasing an additional 5,671 shares during the period. Strong Tower Advisory Services' holdings in Corteva were worth $2,537,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CTVA. Scissortail Wealth Management LLC grew its holdings in shares of Corteva by 72,080.0% during the 4th quarter. Scissortail Wealth Management LLC now owns 3,609 shares of the company's stock worth $206,000 after purchasing an additional 3,604 shares during the period. Van ECK Associates Corp grew its stake in Corteva by 5.9% during the fourth quarter. Van ECK Associates Corp now owns 9,428,206 shares of the company's stock worth $537,031,000 after buying an additional 525,531 shares during the period. JPMorgan Chase & Co. increased its position in shares of Corteva by 6.7% in the third quarter. JPMorgan Chase & Co. now owns 4,605,608 shares of the company's stock worth $270,764,000 after acquiring an additional 288,885 shares in the last quarter. Allworth Financial LP increased its position in shares of Corteva by 17.3% in the fourth quarter. Allworth Financial LP now owns 13,699 shares of the company's stock worth $856,000 after acquiring an additional 2,023 shares in the last quarter. Finally, DnB Asset Management AS raised its stake in shares of Corteva by 39.0% in the 4th quarter. DnB Asset Management AS now owns 232,902 shares of the company's stock valued at $13,266,000 after acquiring an additional 65,334 shares during the period. Hedge funds and other institutional investors own 81.54% of the company's stock.

Corteva Price Performance

CTVA traded up $0.27 during trading on Wednesday, hitting $71.46. The company's stock had a trading volume of 2,776,344 shares, compared to its average volume of 3,312,197. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $48.75 billion, a price-to-earnings ratio of 55.40, a price-to-earnings-growth ratio of 1.68 and a beta of 0.72. The firm's 50 day moving average price is $63.63 and its two-hundred day moving average price is $61.87. Corteva, Inc. has a 12 month low of $50.01 and a 12 month high of $71.85.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $1.13 earnings per share for the quarter, beating analysts' consensus estimates of $0.88 by $0.25. The business had revenue of $4.42 billion during the quarter, compared to analyst estimates of $4.56 billion. Corteva had a net margin of 5.36% and a return on equity of 7.19%. Corteva's revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.89 earnings per share. Sell-side analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Friday, May 2nd will be issued a dividend of $0.17 per share. The ex-dividend date is Monday, June 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.95%. Corteva's dividend payout ratio is presently 41.46%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Barclays upped their price target on Corteva from $64.00 to $70.00 and gave the stock an "equal weight" rating in a report on Wednesday, May 14th. Argus raised shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target for the company in a report on Monday, March 31st. Wells Fargo & Company boosted their price objective on shares of Corteva from $73.00 to $79.00 and gave the stock an "overweight" rating in a report on Monday, May 12th. Royal Bank of Canada raised their target price on Corteva from $72.00 to $73.00 and gave the company an "outperform" rating in a research note on Friday, February 7th. Finally, Morgan Stanley boosted their price target on Corteva from $65.00 to $71.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, Corteva presently has a consensus rating of "Moderate Buy" and an average target price of $70.50.

Check Out Our Latest Stock Report on Corteva

Corteva Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Further Reading

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Should You Invest $1,000 in Corteva Right Now?

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines